ATE424120T1 - Betainhaltige nahrung gegen muskelschwund - Google Patents

Betainhaltige nahrung gegen muskelschwund

Info

Publication number
ATE424120T1
ATE424120T1 AT05808556T AT05808556T ATE424120T1 AT E424120 T1 ATE424120 T1 AT E424120T1 AT 05808556 T AT05808556 T AT 05808556T AT 05808556 T AT05808556 T AT 05808556T AT E424120 T1 ATE424120 T1 AT E424120T1
Authority
AT
Austria
Prior art keywords
muscle wasting
foods containing
prevent muscle
containing betaine
betaine
Prior art date
Application number
AT05808556T
Other languages
English (en)
Inventor
Johannes Peters
Norren Klaske Van
Marchel Gorselink
Robert Hageman
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of ATE424120T1 publication Critical patent/ATE424120T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)
  • Seasonings (AREA)
AT05808556T 2005-10-07 2005-10-07 Betainhaltige nahrung gegen muskelschwund ATE424120T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2005/050010 WO2007043857A1 (en) 2005-10-07 2005-10-07 Nutrition comprising betaine against muscle wasting

Publications (1)

Publication Number Publication Date
ATE424120T1 true ATE424120T1 (de) 2009-03-15

Family

ID=36499171

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05808556T ATE424120T1 (de) 2005-10-07 2005-10-07 Betainhaltige nahrung gegen muskelschwund

Country Status (8)

Country Link
US (1) US20080267941A1 (de)
EP (1) EP1931223B1 (de)
CN (1) CN101277617A (de)
AT (1) ATE424120T1 (de)
BR (1) BRPI0520593A2 (de)
DE (1) DE602005013133D1 (de)
ES (1) ES2323143T3 (de)
WO (1) WO2007043857A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020272040C1 (en) 2019-04-10 2024-03-28 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for treating homocystinuria and other conditions
CN110585266A (zh) * 2019-09-18 2019-12-20 广东润和生物科技有限公司 紫苏籽油与辅酶q10组合物的应用
WO2022098908A1 (en) 2020-11-05 2022-05-12 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for treating homocystinuria and other conditions using polyamines
US20230390234A1 (en) * 2021-02-26 2023-12-07 Ex Healthcare Inc. Composition inhibiting muscle loss or promoting muscle formation through skin-derived exosomes
CN115868634A (zh) * 2021-09-28 2023-03-31 深圳芙莱特营养与健康有限公司 一种增强耐力的组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040043013A1 (en) * 2000-12-28 2004-03-04 Mccleary Edward Larry Metabolic uncoupling therapy
US7740878B2 (en) * 2001-10-22 2010-06-22 Danisco A/S Use of betaine to enhance exercise performance
US20040156882A1 (en) * 2002-10-23 2004-08-12 Davenport David F. Method and composition for feeding mammals
US7160565B2 (en) * 2003-03-31 2007-01-09 Breakthru Products, Llc Hydration beverage and method of delivering nutrients
US8703209B2 (en) * 2003-06-17 2014-04-22 Edward Larry McCleary Composition and method for modulating hydrogen ion physiology

Also Published As

Publication number Publication date
BRPI0520593A2 (pt) 2009-10-06
EP1931223B1 (de) 2009-03-04
EP1931223A1 (de) 2008-06-18
DE602005013133D1 (de) 2009-04-16
WO2007043857A1 (en) 2007-04-19
ES2323143T3 (es) 2009-07-07
US20080267941A1 (en) 2008-10-30
CN101277617A (zh) 2008-10-01

Similar Documents

Publication Publication Date Title
DK1773361T4 (da) Sammensætning baseret på probiotiske bakterier og anvendelse deraf til forebyggelse og/eller behandling af respiratoriske sygdomme
UA94221C2 (en) Lipocalin protein
MY147247A (en) Organic compounds and their uses
EP2007385A4 (de) Kardiovaskuläre zusammensetzung und ihre verwendung zur behandlung von morbus alzheimer
NO20075009L (no) Ernaeringstilsetning for HIV-pasienter
ATE551063T1 (de) Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen
MY155710A (en) Composition for regulating lipid metabolism
EP1912650B8 (de) Verwendung von flibanserin bei der behandlung von fettsucht
AU314489S (en) Multimedia controller
IL187565A0 (en) Compositions and methods for the treatment or prevention of chemoresistant neoplasia
WO2008046865A3 (en) Long-term feed - elderly
WO2010077339A3 (en) β-ARRESTIN EFFECTORS AND COMPOSITIONS AND METHODS OF USE THEREOF
WO2008042101A3 (en) Probiotics for use in reducing the incidence and duration of illness
SI1848415T1 (sl) Kombinacijska terapija z glatiramer acetatom in razagilinom za zdravljenje muliple skleroze
PH12013500761A1 (en) Cysteine and food intake
PL1958522T3 (pl) Funkcjonalny produkt żywnościowy mający pozytywne działania w zapobieganiu chorobom sercowo-naczyniowym
AU314047S (en) Foodstuffs form
IL201426A0 (en) Drug combination and its use in the treatment of muscle loss
DE602005013133D1 (de) Betainhaltige nahrung gegen muskelschwund
ZA200800035B (en) Prevention and treatment of osteochondrosis in animals and humans
AU311982S (en) Chair
EP1997487A4 (de) Produkt zur verwendung bei der verhinderung und behandlung von herzgefässerkrankungen, krebs und entzündungskrankheiten
EP1725869A4 (de) Man2as als modifikatoren des iger-wegs und verwendungsverfahren
GB0604022D0 (en) Element deficiency and prevention treatment
HK1121756A (en) SUBSTITUTED 2-AMINOPYRIMIDINE-4-ONES, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF Aß-RELATED PATHOLOGIES

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties